SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,303 | -34.2% | 39,583 | -28.3% | 0.00% | -33.3% |
| Q2 2023 | $1,658,680 | -50.2% | 55,179 | -39.9% | 0.00% | -50.0% |
| Q1 2023 | $3,328,450 | +52.3% | 91,870 | +50.0% | 0.01% | +50.0% |
| Q4 2022 | $2,185,108 | +570.3% | 61,259 | +535.1% | 0.00% | +300.0% |
| Q3 2022 | $326,000 | +359.2% | 9,646 | +289.6% | 0.00% | – |
| Q2 2022 | $71,000 | -96.5% | 2,476 | -96.0% | 0.00% | -100.0% |
| Q1 2022 | $2,003,000 | +4.9% | 61,989 | -5.4% | 0.00% | +50.0% |
| Q4 2021 | $1,909,000 | – | 65,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |